Additionally, members of the MAP3K family, such as MAP3K5 (ASK1) and MAP3K14 (NIK), are known to be important in kidney disease [44], suggesting that modulating MAP3K11 activity could be a promising therapeutic strategy. This evidence concerns the gene MAP3K14 and kidney disorder.